My posts are only my own opinion. Do not rely on anyone! Do your own DD until satisfied!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just maybe things will change!
https://www.otcmarkets.com/stock/HAON/news/Halitron-Inc-Tops-Estimates-31-in-Sales-Over-Previous-Quarter?id=201032
I pretty much agree with you!
At this point it's still a good entry if you find the right exit! Good luck!
Barchart still shows as buy! https://www.barchart.com/stocks/quotes/HAON/opinion
Potential is big!
There are some good promises in here.
https://www.otcmarkets.com/stock/ONCI/news/ON4-Communication-Announces-June-15-Letter-to-Shareholders?id=195620
Time to turn upwards!
Yes, good entry, nice job!
Nice entry!
Aaah, I missed the .065 entry.
Ayyaaa... What's happening?
Probably that's why the shares aren't moving?
How about this report, happy with it?
https://backend.otcmarkets.com/otcapi/company/financial-report/199944/content
Is everyone happy with the suppl report?
https://backend.otcmarkets.com/otcapi/company/financial-report/199942/content
Is everyone happy with this report?
https://backend.otcmarkets.com/otcapi/company/financial-report/199942/content
Yes I hope so too! Good news! Retailiom is positioned to grow sales of Halitron, by over 200% over the next calendar year.
Halitron is expecting to release its Q2 operating results before the market open on August 15.
Retailiom was created to repackage select assets into one focus due to the broadening nature of the products sold to retailers and distributors who resell to retailers. The “Retail” part of our name designates our target customer base and our objective is to manufacture and sell high quality point of purchase products that improve the aesthetics of retailers’ shelves by keeping them clean, neat, and well organized. We also deliver quickly at reasonable prices. The “iom” in the name represents the vast assortment of over 10,000 products offered and the ability for customization on both paper and plastic.
With our new customer portal www.retailiom.com is seamlessly filling orders online as the Company has launched a target marketing campaign including email, outbound calls, and catalog mailings to further increase sales. Our complete infrastructure includes 2-color off set press and digital printing, cutting, packaging, and other ancillary functions to fill orders within one-to-two business days for our wide array of customers and their diverse needs.
We'll soon be there!
RBNW 52-Week High 0.0860
The Sky is the limit! Go HAON!
We need to see .001 and above from now on!
52 week high .0013 https://www.barchart.com/stocks/quotes/HAON/cheat-sheet
Share Structure
Market Cap
8,143,490
08/13/2018
Authorized Shares
5,030,000,000
03/15/2018
Outstanding Shares
4,286,047,369
03/15/2018
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
2,502,461,960
03/15/2018
Par Value
ONCI CEO says:
CANNABIS
We have decided which company in Canada we would like to be with and we will be having a conference call with the Vancouver based co to discuss plans within 2 weeks. The market has become so hot that many of the companies are increasing their land holdings and the cost for good growing land has shot through the roof.
I will be traveling to Vancouver in July.
HEXAGON
As I have stated we are still waiting for the name change and re domicile to be approved. That being said, if it does not occur by July 4th, I will be reducing the OS by the stated 1.4 billion and will reduce the AS when the approval to Hexagon occurs. YES THAT’S RIGHT YOU HEARD IT CORRECT, IF THE CHANGE DOES NOT OCCUR BY JULY 4 I WILL REDUCE THE OS BY 1.4 BILLION SHARES.
Shouldn't ONCI be at least over .02 - .03 by now?
CEO says: I’m happy to start this update off by saying we reported record revenue of $1,073,000 for the quarter ending April 30, 2018 vs $307,754 in the same quarter last year and an increase over last quarter revenue. We have signed huge deals last quarter and our growth continues to rise as demand for our products increase dramatically.
Reshape Lifesciences Q2 EPS $(15.78) May Not Compare To $(1.80) Estimate, Sales $653K Miss $1.02M Estimate
Benzinga Newsdesk , Benzinga Staff Writer FOLLOW
August 14, 2018 4:51pm Comments
Go figure, losing $15.78 per share on a stock that's trading at around .10 per share.
History shows big drop in price at earnings.
Earnings announcement* for RSLS: Aug 14, 2018. ReShape Lifesciences Inc. is expected* to report earnings on 08/14/2018 after market close. The report will be for the fiscal Quarter ending Jun 2018. The reported EPS for the same quarter last year was $-13.64.
ReShape Lifesciences Inc. (RSLS) Earnings Report Date - NASDAQ ...
https://www.nasdaq.com/earnings/report/rsls
Earnings announcement* for RSLS: Aug 14, 2018. ReShape Lifesciences Inc. is expected* to report earnings on 08/14/2018 after market close. The report will be for the fiscal Quarter ending Jun 2018. The reported EPS for the same quarter last year was $-13.64.
ReShape Lifesciences Inc. (RSLS) Earnings Report Date - NASDAQ ...
https://www.nasdaq.com/earnings/report/rsls
Yes, been in ETRM multiple times a while back.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 8, 2018, the Board of Directors of the Company, upon the recommendation of the Nominating and Governance Committee, elected Arda Minocherhomjee as a new director, effective as of August 13, 2018. The size of the Board was increased from four to five members in connection with Mr. Minocherhomjee’s election. Mr. Minocherhomjee was elected to serve as a Class III director for a term expiring at the 2019 Annual Meeting of Stockholders and will initially serve on the Board’s Audit Committee and Compensation Committee.
The Board determined that Mr. Minocherhomjee meets applicable director independence standards. There is no arrangement or understanding between Mr. Minocherhomjee and any other persons pursuant to which he was selected as a director. There are no related party transactions between Mr. Minocherhomjee and the Company.
Mr. Minocherhomjee will receive the standard compensation for the Company’s non-employee directors, as described under the caption “Director Compensation” in the Company’s definitive proxy statement for its 2018 Annual Meeting of Stockholders, which was filed with the Securities and Exchange Commission on April 30, 2018.
In connection with the Company’s underwritten public offering of shares of common stock at a public offering price of $0.085 per share that was announced on August 7, 2018 and terminated on August 10, 2018, the conversion price of the Company’s outstanding shares of series B convertible preferred stock and series D convertible preferred stock, and the exercise price of the warrants to purchase common stock issued in connection therewith, was reduced to $0.085 in accordance with their terms. At the close of business on August 10, 2018, and taking into account the conversion by certain holders of shares of the Company’s outstanding series B convertible preferred stock and series D convertible preferred stock into shares of common stock at a conversion price of $0.085 per share, the Company had the following securities outstanding:
· 33,548,621 shares of our common stock;
· 37,376,917 shares of our common stock issuable upon conversion of 3,177.04 shares of series D convertible preferred stock;
· 635,920 shares of our common stock issuable upon conversion of 95,388 shares of series C convertible preferred stock;
· 7,541,177 shares of our common stock issuable upon conversion of 641 shares of series B convertible preferred stock;
· 6,379,636 shares of our common stock issuable upon the exercise of warrants, with exercise prices ranging from $0.085 to $33,000;